| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG1 CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 TMEM38B CHRNA5 CHRNB1 ZACN ANO6 SLC19A1 SCN7A GHITM KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 1.09e-09 | 793 | 117 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRG1 OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 CHRNA5 CHRNB1 OR4L1 OPRD1 OPRK1 ZACN OR12D2 OR12D1 OR4A16 SCARB2 OR52E8 SCN7A OR5L2 OR4X1 OR4C5 GABRA6 | 3.11e-09 | 1353 | 117 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG1 CACNA1E SLC36A1 MPC1L TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 SLC35E2B TMEM38B CHRNA5 CHRNB1 ZACN SLC44A1 ANO6 SLC19A1 SLC35E2A SCN7A GHITM KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 3.53e-09 | 1180 | 117 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRG1 CACNA1E SLC36A1 MPC1L TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 SLC35E2B TMEM38B CHRNA5 CHRNB1 ZACN SLC44A1 ANO6 SLC19A1 SLC35E2A SCN7A GHITM KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 2.17e-08 | 1289 | 117 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 OR4L1 OPRD1 OPRK1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 4.07e-08 | 884 | 117 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 TMEM38B CHRNA5 CHRNB1 ZACN ANO6 SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B | 6.05e-08 | 664 | 117 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRG1 CACNA1E TMC2 TMEM38B CHRNA5 CHRNB1 ZACN ANO6 SCN7A KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 7.79e-08 | 459 | 117 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 2.35e-07 | 431 | 117 | 14 | GO:0004984 |
| GeneOntologyMolecularFunction | channel activity | GABRG1 CACNA1E TMC2 TMEM38B CHRNA5 CHRNB1 ZACN ANO6 SCN7A KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 4.37e-07 | 525 | 117 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRG1 CACNA1E TMC2 TMEM38B CHRNA5 CHRNB1 ZACN ANO6 SCN7A KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 4.47e-07 | 526 | 117 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1E TMC2 TMEM38B CHRNA5 CHRNB1 ZACN ANO6 SCN7A KCNN1 TRPV6 TRPV5 SCN3B | 8.30e-07 | 343 | 117 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG1 CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 TMEM38B ANO6 SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B GABRA6 | 2.02e-06 | 758 | 117 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 TMEM38B SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B | 3.44e-06 | 465 | 117 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 TMEM38B SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B | 1.84e-05 | 627 | 117 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | gated channel activity | GABRG1 CACNA1E TMC2 CHRNA5 CHRNB1 ZACN ANO6 SCN7A KCNN1 GABRA6 | 2.75e-05 | 334 | 117 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 8.94e-05 | 77 | 117 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | cyclic-GMP-AMP transmembrane transporter activity | 1.02e-04 | 3 | 117 | 2 | GO:0140360 | |
| GeneOntologyMolecularFunction | odorant binding | 1.03e-04 | 127 | 117 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.43e-04 | 193 | 117 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.62e-04 | 197 | 117 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.63e-04 | 138 | 117 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.66e-04 | 151 | 117 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 3.37e-04 | 5 | 117 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | thrombin-activated receptor activity | 3.37e-04 | 5 | 117 | 2 | GO:0015057 | |
| GeneOntologyMolecularFunction | guanine nucleotide transmembrane transporter activity | 3.37e-04 | 5 | 117 | 2 | GO:0001409 | |
| GeneOntologyMolecularFunction | proteinase-activated receptor activity | 3.37e-04 | 5 | 117 | 2 | GO:0001648 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC36A1 TMEM165 SLC5A9 SLC35E2B SLC44A1 SLC19A1 SLC35E2A GHITM | 3.58e-04 | 296 | 117 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.75e-04 | 65 | 117 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.75e-04 | 65 | 117 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | L-leucine binding | 7.01e-04 | 7 | 117 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 7.01e-04 | 7 | 117 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.12e-03 | 133 | 117 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 1.19e-03 | 9 | 117 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.29e-03 | 279 | 117 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.41e-03 | 140 | 117 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.41e-03 | 140 | 117 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.81e-03 | 11 | 117 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.97e-03 | 151 | 117 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 2.16e-03 | 12 | 117 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 2.16e-03 | 12 | 117 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 2.40e-03 | 398 | 117 | 8 | GO:0061659 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 2.55e-03 | 13 | 117 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.85e-03 | 100 | 117 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 2.96e-03 | 14 | 117 | 2 | GO:0000340 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.14e-03 | 50 | 117 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.17e-03 | 103 | 117 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 4.37e-03 | 17 | 117 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 4.56e-03 | 57 | 117 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 4.90e-03 | 18 | 117 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 5.26e-03 | 60 | 117 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 5.45e-03 | 19 | 117 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | acyltransferase activity | CUL4A UBR1 UBR2 PIAS2 UBE4A CRLS1 UBE3A MCM3AP NAT10 SYVN1 RNF139 | 5.83e-03 | 775 | 117 | 11 | GO:0016746 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 6.04e-03 | 20 | 117 | 2 | GO:0050664 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 6.35e-03 | 372 | 117 | 7 | GO:0061630 | |
| GeneOntologyMolecularFunction | RNA cap binding | 6.65e-03 | 21 | 117 | 2 | GO:0000339 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.03e-03 | 129 | 117 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC36A1 TMEM165 SLC5A9 SLC35E2B SLC44A1 SLC19A1 SLC35E2A GHITM | 7.07e-03 | 477 | 117 | 8 | GO:0022804 |
| GeneOntologyMolecularFunction | GABA receptor activity | 7.28e-03 | 22 | 117 | 2 | GO:0016917 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRG1 CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 F2R TMEM38B CHRNA5 CHRNB1 OPRK1 ZACN ANO6 SLC19A1 SCN7A GHITM KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 7.80e-09 | 1115 | 114 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRG1 CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 F2R TMEM38B CHRNA5 CHRNB1 OPRD1 OPRK1 ZACN ANO6 SLC19A1 SCN7A GHITM KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 9.81e-08 | 1374 | 114 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 1.18e-07 | 432 | 114 | 14 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2T29 TMC2 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 CHRNA5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 1.32e-07 | 582 | 114 | 16 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 2.88e-07 | 465 | 114 | 14 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception | CACNA1E OR2T29 TMC2 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R CHRNA5 OR4L1 OPRK1 OR12D2 OR12D1 OR4A16 SCARB2 OR52E8 MARVELD2 OR5L2 OR4X1 OR4C5 | 3.76e-07 | 1072 | 114 | 21 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 4.78e-07 | 485 | 114 | 14 | GO:0050907 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRG1 CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 F2R TMEM38B OPRK1 ANO6 SCN7A GHITM KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 7.00e-07 | 1017 | 114 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 1.20e-06 | 524 | 114 | 14 | GO:0009593 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 ADCY9 OR4L1 OPRD1 OPRK1 OR12D2 OR12D1 OR4A16 OR52E8 GNA15 OR5L2 OR4X1 OR4C5 | 1.94e-06 | 1395 | 114 | 23 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 1.98e-06 | 547 | 114 | 14 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2T29 TMC2 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 CHRNA5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 2.28e-06 | 722 | 114 | 16 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 F2R TMEM38B OPRK1 ZACN ANO6 SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B | 4.05e-06 | 942 | 114 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 F2R TMEM38B CHRNB1 OPRD1 OPRK1 ZACN ANO6 SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B | 5.02e-06 | 1157 | 114 | 20 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1E SLC36A1 TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 F2R TMEM38B OPRK1 ANO6 SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B | 1.23e-05 | 922 | 114 | 17 | GO:0098662 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1E TMC2 MRS2 SLC31A1 TMEM165 SLC5A9 F2R TMEM38B OPRD1 OPRK1 ANO6 SCN7A GHITM KCNN1 TRPV6 TRPV5 SCN3B | 3.47e-05 | 1000 | 114 | 17 | GO:0030001 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 9.68e-05 | 133 | 114 | 6 | GO:0007200 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial ATP synthesis coupled electron transport | 1.80e-04 | 4 | 114 | 2 | GO:1905448 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 1.80e-04 | 4 | 114 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | UBR1 UBR2 PSMC6 TMEM38B CHRNA5 CHRNB1 OPRD1 OPRK1 UBE4A DUOX1 CRLS1 CYFIP1 UBE3A TMEM259 GNA15 SYVN1 RNF139 SOS1 | 2.08e-04 | 1272 | 114 | 18 | GO:1901698 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.93e-04 | 230 | 114 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | response to nicotine | 2.98e-04 | 58 | 114 | 4 | GO:0035094 | |
| GeneOntologyBiologicalProcess | regulation of renin secretion into blood stream | 3.00e-04 | 5 | 114 | 2 | GO:1900133 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 3.30e-04 | 392 | 114 | 9 | GO:0070588 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 4.48e-04 | 6 | 114 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 4.48e-04 | 6 | 114 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 4.48e-04 | 6 | 114 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 4.48e-04 | 6 | 114 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 4.97e-04 | 180 | 114 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | ERAD pathway | 5.23e-04 | 119 | 114 | 5 | GO:0036503 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1E TMC2 TMEM165 F2R TMEM38B OPRD1 ANO6 GHITM TRPV6 TRPV5 | 5.27e-04 | 509 | 114 | 10 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 5.30e-04 | 333 | 114 | 8 | GO:0051056 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 5.80e-04 | 69 | 114 | 4 | GO:0098926 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial ATP synthesis coupled electron transport | 6.24e-04 | 7 | 114 | 2 | GO:1905446 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRG1 CACNA1E CHRNA5 CHRNB1 ANO6 SCN7A KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 1.30e-06 | 378 | 116 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRG1 CACNA1E CHRNA5 CHRNB1 ZACN ANO6 SCN7A KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 6.81e-06 | 523 | 116 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | GABRG1 CACNA1E CHRNA5 CHRNB1 ZACN ANO6 SCN7A KCNN1 LRRC8A TRPV6 TRPV5 SCN3B GABRA6 | 1.17e-05 | 550 | 116 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | membrane protein complex | GABRG1 CACNA1E NOX4 CHRNA5 CHRNB1 STT3A DUOX1 ZACN ANO6 SYNE2 SCN7A KCNN1 LRRC8A TRPV6 GNA15 SYVN1 RNF139 TRPV5 SCN3B GABRA6 | 2.07e-04 | 1498 | 116 | 20 | GO:0098796 |
| GeneOntologyCellularComponent | apolipoprotein B mRNA editing enzyme complex | 3.02e-04 | 5 | 116 | 2 | GO:0030895 | |
| GeneOntologyCellularComponent | mRNA editing complex | 6.30e-04 | 7 | 116 | 2 | GO:0045293 | |
| GeneOntologyCellularComponent | Derlin-1 retrotranslocation complex | 8.36e-04 | 8 | 116 | 2 | GO:0036513 | |
| Domain | 7tm_1 | OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 OR4L1 OPRD1 OPRK1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 2.82e-09 | 677 | 111 | 20 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 OR4L1 OPRD1 OPRK1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 3.44e-09 | 685 | 111 | 20 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 OR4L1 OPRD1 OPRK1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 3.99e-09 | 691 | 111 | 20 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 OR4L1 OPRD1 OPRK1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 4.09e-09 | 692 | 111 | 20 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR2T29 OXER1 GPR18 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 F2R F2RL1 BDKRB2 OR4L1 OPRD1 OPRK1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 | 1.43e-08 | 670 | 111 | 19 | IPR017452 |
| Domain | Olfact_rcpt | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 6.06e-07 | 393 | 111 | 13 | IPR000725 |
| Domain | Neurotransmitter_ion_chnl_CS | 6.85e-06 | 45 | 111 | 5 | IPR018000 | |
| Domain | Neur_chan_LBD | 8.51e-06 | 47 | 111 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 8.51e-06 | 47 | 111 | 5 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 8.51e-06 | 47 | 111 | 5 | IPR006029 | |
| Domain | - | 8.51e-06 | 47 | 111 | 5 | 2.70.170.10 | |
| Domain | Neur_channel | 8.51e-06 | 47 | 111 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 8.51e-06 | 47 | 111 | 5 | IPR006202 | |
| Domain | ClpS_core | 3.50e-05 | 2 | 111 | 2 | IPR003769 | |
| Domain | Cytoplasmic_FMR1-int | 3.50e-05 | 2 | 111 | 2 | IPR008081 | |
| Domain | TRPV5/TRPV6 | 3.50e-05 | 2 | 111 | 2 | IPR008344 | |
| Domain | ClpS | 3.50e-05 | 2 | 111 | 2 | PF02617 | |
| Domain | FragX_IP | 3.50e-05 | 2 | 111 | 2 | PF05994 | |
| Domain | Ribosomal_L7/12_C/ClpS-like | 1.05e-04 | 3 | 111 | 2 | IPR014719 | |
| Domain | - | 1.05e-04 | 3 | 111 | 2 | 3.30.1390.10 | |
| Domain | Neur_chan_memb | 1.59e-04 | 46 | 111 | 4 | PF02932 | |
| Domain | ARM-type_fold | 1.92e-04 | 339 | 111 | 9 | IPR016024 | |
| Domain | DUF1394 | 2.08e-04 | 4 | 111 | 2 | PF07159 | |
| Domain | Opioid_rcpt | 2.08e-04 | 4 | 111 | 2 | IPR001418 | |
| Domain | Protea_act_rcpt | 2.08e-04 | 4 | 111 | 2 | IPR003912 | |
| Domain | DUF1394 | 2.08e-04 | 4 | 111 | 2 | IPR009828 | |
| Domain | - | 3.32e-04 | 23 | 111 | 3 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 3.32e-04 | 23 | 111 | 3 | IPR027361 | |
| Domain | HnRNP_R/Q_splicing_fac | 3.46e-04 | 5 | 111 | 2 | IPR006535 | |
| Domain | NAD_binding_6 | 7.21e-04 | 7 | 111 | 2 | PF08030 | |
| Domain | ZF_UBR | 7.21e-04 | 7 | 111 | 2 | PS51157 | |
| Domain | FAD_binding_8 | 7.21e-04 | 7 | 111 | 2 | PF08022 | |
| Domain | zf-UBR | 7.21e-04 | 7 | 111 | 2 | PF02207 | |
| Domain | Znf_UBR | 7.21e-04 | 7 | 111 | 2 | IPR003126 | |
| Domain | FAD-bd_8 | 7.21e-04 | 7 | 111 | 2 | IPR013112 | |
| Domain | ZnF_UBR1 | 7.21e-04 | 7 | 111 | 2 | SM00396 | |
| Domain | Fe_red_NAD-bd_6 | 7.21e-04 | 7 | 111 | 2 | IPR013121 | |
| Domain | Sugar_P_trans_dom | 1.53e-03 | 10 | 111 | 2 | IPR004853 | |
| Domain | TPT | 1.53e-03 | 10 | 111 | 2 | PF03151 | |
| Domain | TRP_channel | 1.86e-03 | 11 | 111 | 2 | IPR004729 | |
| Domain | Ferric_reduct | 2.22e-03 | 12 | 111 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 2.22e-03 | 12 | 111 | 2 | IPR013130 | |
| Domain | IBN_N | 3.49e-03 | 15 | 111 | 2 | PF03810 | |
| Domain | IBN_N | 3.98e-03 | 16 | 111 | 2 | SM00913 | |
| Domain | Nicotinic_acetylcholine_rcpt | 3.98e-03 | 16 | 111 | 2 | IPR002394 | |
| Domain | Importin-beta_N | 4.49e-03 | 17 | 111 | 2 | IPR001494 | |
| Domain | Ion_trans_dom | 4.78e-03 | 114 | 111 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.78e-03 | 114 | 111 | 4 | PF00520 | |
| Domain | ARM-like | 5.52e-03 | 270 | 111 | 6 | IPR011989 | |
| Domain | Fd_Rdtase_FAD-bd | 5.60e-03 | 19 | 111 | 2 | IPR017927 | |
| Domain | FAD_FR | 5.60e-03 | 19 | 111 | 2 | PS51384 | |
| Domain | Myosin-like_IQ_dom | 5.60e-03 | 19 | 111 | 2 | IPR027401 | |
| Domain | - | 5.60e-03 | 19 | 111 | 2 | 4.10.270.10 | |
| Domain | Riboflavin_synthase-like_b-brl | 5.60e-03 | 19 | 111 | 2 | IPR017938 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 3.77e-06 | 417 | 94 | 13 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR2T29 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 | 1.02e-05 | 389 | 94 | 12 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2T29 TMC2 OR7A5 OR6K2 OR10Q1 OR14I1 OR2T5 OR4L1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 7.74e-05 | 636 | 94 | 14 | M41834 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 8.25e-05 | 272 | 94 | 9 | M13380 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2T29 OR7A5 OR6K2 OR10Q1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4C5 | 1.92e-09 | 340 | 117 | 12 | 11875048 |
| Pubmed | OR2T29 OR7A5 OR6K2 OR10Q1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4C5 | 1.92e-09 | 340 | 117 | 12 | 11802173 | |
| Pubmed | OR2T29 OR7A5 OR6K2 OR10Q1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4C5 | 2.12e-09 | 343 | 117 | 12 | 32295537 | |
| Pubmed | OR2T29 OR7A5 OR6K2 OR10Q1 OR2T5 OR4L1 OR12D2 OR12D1 OR4A16 OR52E8 OR5L2 OR4C5 | 2.34e-09 | 346 | 117 | 12 | 14611657 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 1.96e-07 | 74 | 117 | 6 | 15081110 | |
| Pubmed | OR7A5 OR6K2 OR10Q1 OR2T5 OR4L1 OR12D2 OR4A16 OR52E8 OR5L2 OR4X1 OR4C5 | 2.29e-06 | 541 | 117 | 11 | 14983052 | |
| Pubmed | Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. | 3.07e-06 | 9 | 117 | 3 | 17855541 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PRPSAP2 TMEM165 ZMYND8 SIK3 PIAS2 ADCY9 CYFIP2 CRLS1 CYFIP1 NF1 DNAH17 NAT10 ASPM RBM47 SCN3B SLC66A3 | 4.32e-06 | 1242 | 117 | 16 | 30973865 |
| Pubmed | 7.66e-06 | 296 | 117 | 8 | 34186245 | ||
| Pubmed | HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. | 7.98e-06 | 12 | 117 | 3 | 17360488 | |
| Pubmed | 8.22e-06 | 38 | 117 | 4 | 22908908 | ||
| Pubmed | 8.44e-06 | 300 | 117 | 8 | 19086053 | ||
| Pubmed | TMEM165 PSMC6 TEAD1 SMC5 UBE4A SLC44A1 NF1 FAR2 UBE3A MCM3AP ASPM FLCN NUP188 SYVN1 RNF139 SOS1 | 9.89e-06 | 1327 | 117 | 16 | 32694731 | |
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 1.04e-05 | 221 | 117 | 7 | 31950832 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 8784787 | ||
| Pubmed | The chromatin-binding protein Smyd1 restricts adult mammalian heart growth. | 1.12e-05 | 2 | 117 | 2 | 27663768 | |
| Pubmed | Bound Waters Mediate Binding of Diverse Substrates to a Ubiquitin Ligase. | 1.12e-05 | 2 | 117 | 2 | 28392261 | |
| Pubmed | Proteinase-activated receptors 1 and 2 exert opposite effects on renal renin release. | 1.12e-05 | 2 | 117 | 2 | 21859963 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20178461 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22354706 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 18757438 | ||
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 1.12e-05 | 2 | 117 | 2 | 16564089 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16331961 | ||
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 1.12e-05 | 2 | 117 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 1.12e-05 | 2 | 117 | 2 | 23968883 | |
| Pubmed | SLC35E2 promoter mutation as a prognostic marker of esophageal squamous cell carcinoma. | 1.12e-05 | 2 | 117 | 2 | 35247439 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11447194 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12390878 | ||
| Pubmed | Expression of and functional responses to protease-activated receptors on human eosinophils. | 1.12e-05 | 2 | 117 | 2 | 12832443 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12370395 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30995477 | ||
| Pubmed | Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6. | 1.12e-05 | 2 | 117 | 2 | 12574114 | |
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 1.12e-05 | 2 | 117 | 2 | 38128786 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 14535952 | ||
| Pubmed | Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway. | 1.12e-05 | 2 | 117 | 2 | 20298436 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 19941849 | ||
| Pubmed | Identification of kappa- and delta-opioid receptor transcripts in immune cells. | 1.12e-05 | 2 | 117 | 2 | 7649271 | |
| Pubmed | Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. | 1.12e-05 | 2 | 117 | 2 | 11549322 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 19140341 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28878117 | ||
| Pubmed | The thrombin receptor is a critical extracellular switch controlling myelination. | 1.12e-05 | 2 | 117 | 2 | 25628003 | |
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 1.12e-05 | 2 | 117 | 2 | 30916584 | |
| Pubmed | Tead1 is essential for mitochondrial function in cardiomyocytes. | 1.12e-05 | 2 | 117 | 2 | 32502376 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22406075 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12372769 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26600192 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23637930 | ||
| Pubmed | Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. | 1.12e-05 | 2 | 117 | 2 | 24923251 | |
| Pubmed | Proteinase-activated receptors 1 and 2 mediate contraction of human oesophageal muscularis mucosae. | 1.12e-05 | 2 | 117 | 2 | 19694963 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16565876 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16606826 | ||
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 1.12e-05 | 2 | 117 | 2 | 24357318 | |
| Pubmed | Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. | 1.12e-05 | 2 | 117 | 2 | 8393575 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24278116 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 18832729 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 17404307 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27979585 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16311597 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 21633703 | ||
| Pubmed | Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6. | 1.12e-05 | 2 | 117 | 2 | 16705151 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24759133 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11316510 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20413722 | ||
| Pubmed | Proteases in agricultural dust induce lung inflammation through PAR-1 and PAR-2 activation. | 1.12e-05 | 2 | 117 | 2 | 26092994 | |
| Pubmed | G-protein-coupled receptor heterodimerization modulates receptor function. | 1.12e-05 | 2 | 117 | 2 | 10385123 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15548684 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24717606 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22764053 | ||
| Pubmed | 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. | 1.12e-05 | 2 | 117 | 2 | 17965715 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20405023 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 19080851 | ||
| Pubmed | A novel role for copper in Ras/mitogen-activated protein kinase signaling. | 1.12e-05 | 2 | 117 | 2 | 22290441 | |
| Pubmed | A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. | 1.12e-05 | 2 | 117 | 2 | 11846401 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25164318 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 17622222 | ||
| Pubmed | Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer. | 1.12e-05 | 2 | 117 | 2 | 24177339 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15743797 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 38203540 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25200274 | ||
| Pubmed | Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. | 1.12e-05 | 2 | 117 | 2 | 15280447 | |
| Pubmed | Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy. | 1.12e-05 | 2 | 117 | 2 | 23832758 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 9918574 | ||
| Pubmed | Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia. | 1.12e-05 | 2 | 117 | 2 | 21940952 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24761864 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20444417 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 34327661 | ||
| Pubmed | Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the Ca(2+)-sensor calmodulin. | 1.12e-05 | 2 | 117 | 2 | 15123711 | |
| Pubmed | Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart. | 1.12e-05 | 2 | 117 | 2 | 30061404 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12077127 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20215560 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 21905006 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16712978 | ||
| Pubmed | Structural basis of substrate recognition and specificity in the N-end rule pathway. | 1.12e-05 | 2 | 117 | 2 | 20835242 | |
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 1.12e-05 | 2 | 117 | 2 | 29752658 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 35567753 | ||
| Pubmed | Single-channel activities of the human epithelial Ca2+ transport proteins CaT1 and CaT2. | 1.12e-05 | 2 | 117 | 2 | 11719848 | |
| Pubmed | Concerted action of associated proteins in the regulation of TRPV5 and TRPV6. | 1.12e-05 | 2 | 117 | 2 | 17233615 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24592736 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 31324746 | ||
| Pubmed | Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis. | 1.12e-05 | 2 | 117 | 2 | 25689283 | |
| Interaction | C3orf18 interactions | 3.02e-06 | 115 | 109 | 7 | int:C3orf18 | |
| Interaction | GNA15 interactions | 1.10e-05 | 26 | 109 | 4 | int:GNA15 | |
| Interaction | EDEM1 interactions | 1.42e-05 | 202 | 109 | 8 | int:EDEM1 | |
| Interaction | LRRC8B interactions | 2.94e-05 | 33 | 109 | 4 | int:LRRC8B | |
| Interaction | GPRASP1 interactions | 3.12e-05 | 67 | 109 | 5 | int:GPRASP1 | |
| Interaction | VSIG1 interactions | 4.43e-05 | 72 | 109 | 5 | int:VSIG1 | |
| Interaction | OPRK1 interactions | 5.36e-05 | 14 | 109 | 3 | int:OPRK1 | |
| Interaction | RAC1 interactions | PRPSAP2 ARHGAP32 ADCY9 STT3A CYFIP2 DOCK5 CYFIP1 DST NF1 ANO6 SLC19A1 MCM3AP LRRC8A MARVELD2 LRBA XPOT SOS1 | 5.51e-05 | 1063 | 109 | 17 | int:RAC1 |
| Interaction | HERC5 interactions | 5.62e-05 | 245 | 109 | 8 | int:HERC5 | |
| Cytoband | 11q23.3 | 4.94e-05 | 78 | 117 | 4 | 11q23.3 | |
| Cytoband | 6p22.2-p21.31 | 6.41e-05 | 5 | 117 | 2 | 6p22.2-p21.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q13 | 6.40e-04 | 152 | 117 | 4 | chr5q13 | |
| Cytoband | 9q31.2 | 7.55e-04 | 16 | 117 | 2 | 9q31.2 | |
| Cytoband | 12q14.2 | 8.54e-04 | 17 | 117 | 2 | 12q14.2 | |
| Cytoband | 5q13 | 1.44e-03 | 22 | 117 | 2 | 5q13 | |
| Cytoband | 15q15.3 | 1.86e-03 | 25 | 117 | 2 | 15q15.3 | |
| Cytoband | 1q44 | 2.86e-03 | 110 | 117 | 3 | 1q44 | |
| GeneFamily | Olfactory receptors, family 12 | 6.69e-05 | 3 | 86 | 2 | 160 | |
| GeneFamily | F2R receptors | 1.33e-04 | 4 | 86 | 2 | 219 | |
| GeneFamily | Opioid receptors | 1.33e-04 | 4 | 86 | 2 | 245 | |
| GeneFamily | Exportins | 4.62e-04 | 7 | 86 | 2 | 547 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 4.62e-04 | 7 | 86 | 2 | 785 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.57e-03 | 16 | 86 | 2 | 173 | |
| GeneFamily | Solute carriers | 2.75e-03 | 395 | 86 | 7 | 752 | |
| GeneFamily | Olfactory receptors, family 4 | 3.34e-03 | 129 | 86 | 4 | 151 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.63e-03 | 19 | 86 | 2 | 563 | |
| GeneFamily | Zinc fingers MYND-type | 4.43e-03 | 21 | 86 | 2 | 87 | |
| Coexpression | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP | 9.85e-06 | 323 | 111 | 9 | M15107 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 1.62e-05 | 344 | 111 | 9 | M2239 | |
| Coexpression | GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP | 2.36e-05 | 200 | 111 | 7 | M3048 | |
| Coexpression | GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 2.36e-05 | 200 | 111 | 7 | M6997 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | RIN3 TMEM165 ZMYND8 TMEM38B ADCY9 NF1 FAR2 UBE3A MCM3AP SYNE2 NAT10 RNF139 SOS1 | 3.04e-05 | 790 | 111 | 13 | M12490 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | CUL4A SLC36A1 ZMYND8 SLC35E2B STT3A UBE4A TMEM259 ANO6 SLC19A1 SLC35E2A SYVN1 XPOT | 4.41e-05 | 703 | 111 | 12 | MM1055 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.69e-05 | 111 | 103 | 6 | gudmap_developingKidney_e11.5_ureteric bud_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#2_top-relative-expression-ranked_500 | 4.13e-05 | 79 | 103 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_500_k2 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.65e-06 | 166 | 115 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-06 | 183 | 115 | 6 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 198 | 115 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 115 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 115 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| Drug | capsazepine | 4.29e-06 | 84 | 115 | 6 | CID002733484 | |
| Drug | AC1NSM1F | 1.03e-05 | 9 | 115 | 3 | CID005312118 | |
| Drug | tetradotoxin | GABRG1 CACNA1E F2RL1 CHRNB1 OPRD1 OPRK1 SCN7A KCNN1 TRPV5 SCN3B GABRA6 | 1.12e-05 | 428 | 115 | 11 | CID000020382 |
| Drug | procaine | 1.29e-05 | 153 | 115 | 7 | CID000004914 | |
| Drug | methanethiosulfonate | 1.40e-05 | 103 | 115 | 6 | CID004188587 | |
| Drug | pentobarbital | 1.86e-05 | 224 | 115 | 8 | CID000004737 | |
| Drug | gabapentin | 2.45e-05 | 169 | 115 | 7 | CID000003446 | |
| Drug | erinacine E | 2.53e-05 | 2 | 115 | 2 | CID005317180 | |
| Drug | Dynorphin (1-11) | 2.53e-05 | 2 | 115 | 2 | CID003086114 | |
| Drug | (-)-EKC | 2.53e-05 | 2 | 115 | 2 | CID000042800 | |
| Drug | 2-aminooxazole | 2.53e-05 | 2 | 115 | 2 | CID000558521 | |
| Drug | MR-1353 | 2.53e-05 | 2 | 115 | 2 | CID000197198 | |
| Drug | trefentanil | 2.53e-05 | 2 | 115 | 2 | CID000060727 | |
| Drug | Tubocurarine | 2.62e-05 | 69 | 115 | 5 | ctd:D014403 | |
| Drug | U-93631 | 2.67e-05 | 12 | 115 | 3 | CID000197626 | |
| Drug | riluzole | 2.95e-05 | 174 | 115 | 7 | CID000005070 | |
| Drug | Barium | 3.22e-05 | 72 | 115 | 5 | ctd:D001464 | |
| Drug | BAPTA | 4.02e-05 | 324 | 115 | 9 | CID000104751 | |
| Drug | 2-aminoethyl diphenylborinate | 4.58e-05 | 127 | 115 | 6 | CID000001598 | |
| Drug | baclofen | 5.35e-05 | 191 | 115 | 7 | CID000002284 | |
| Drug | AC1L1I54 | 5.41e-05 | 41 | 115 | 4 | CID000004426 | |
| Drug | Fk 888 | 5.96e-05 | 42 | 115 | 4 | CID000107967 | |
| Drug | QX-314 | 6.03e-05 | 82 | 115 | 5 | CID000003925 | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.09e-05 | 195 | 115 | 7 | 1207_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 5292_DN | |
| Drug | Naltrexone | 6.70e-05 | 16 | 115 | 3 | ctd:D009271 | |
| Drug | enadoline | 6.70e-05 | 16 | 115 | 3 | CID000060767 | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 2399_DN | |
| Drug | TRK 820 | 7.56e-05 | 3 | 115 | 2 | ctd:C111212 | |
| Drug | Oxycodone | 7.56e-05 | 3 | 115 | 2 | DB00497 | |
| Drug | Hydromorphone | 7.56e-05 | 3 | 115 | 2 | DB00327 | |
| Drug | Codeine | 7.56e-05 | 3 | 115 | 2 | DB00318 | |
| Drug | Carfentanil | 7.56e-05 | 3 | 115 | 2 | DB01535 | |
| Drug | Morphine | 7.56e-05 | 3 | 115 | 2 | DB00295 | |
| Drug | Hydrocodone | 7.56e-05 | 3 | 115 | 2 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 7.56e-05 | 3 | 115 | 2 | DB01571 | |
| Drug | Heroin | 7.56e-05 | 3 | 115 | 2 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 7.56e-05 | 3 | 115 | 2 | DB01439 | |
| Drug | morphine-7,8-oxide | 7.56e-05 | 3 | 115 | 2 | CID005491901 | |
| Drug | Levorphanol | 7.56e-05 | 3 | 115 | 2 | ctd:D007981 | |
| Drug | Levallorphan | 7.56e-05 | 3 | 115 | 2 | ctd:D007977 | |
| Drug | TMC-2A | 7.56e-05 | 3 | 115 | 2 | CID006918376 | |
| Drug | NSC11411 | 7.56e-05 | 3 | 115 | 2 | CID000408117 | |
| Drug | Buprenorphine | 7.56e-05 | 3 | 115 | 2 | DB00921 | |
| Drug | Levorphanol | 7.56e-05 | 3 | 115 | 2 | DB00854 | |
| Drug | Remifentanil | 7.56e-05 | 3 | 115 | 2 | DB00899 | |
| Drug | Nalbuphine | 7.56e-05 | 3 | 115 | 2 | DB00844 | |
| Drug | Fentanyl | 7.56e-05 | 3 | 115 | 2 | DB00813 | |
| Drug | Sufentanil | 7.56e-05 | 3 | 115 | 2 | DB00708 | |
| Drug | Ro 64-6198 | 7.56e-05 | 3 | 115 | 2 | CID009844019 | |
| Drug | Propoxyphene | 7.56e-05 | 3 | 115 | 2 | DB00647 | |
| Drug | Butorphanol | 7.56e-05 | 3 | 115 | 2 | DB00611 | |
| Drug | Butorphanol | 7.56e-05 | 3 | 115 | 2 | ctd:D002077 | |
| Drug | cyclorphan | 7.56e-05 | 3 | 115 | 2 | ctd:C084603 | |
| Drug | up hit | 7.56e-05 | 3 | 115 | 2 | CID000129713 | |
| Drug | Alvimopan | 7.56e-05 | 3 | 115 | 2 | DB06274 | |
| Drug | dextrallorphan | 7.56e-05 | 3 | 115 | 2 | ctd:C044130 | |
| Drug | 14-phenylpropoxymetopon | 7.56e-05 | 3 | 115 | 2 | ctd:C478565 | |
| Drug | NSC612112 | 7.56e-05 | 3 | 115 | 2 | CID000356432 | |
| Drug | indolin-3-one | 7.56e-05 | 3 | 115 | 2 | CID000230915 | |
| Drug | naloxazine | 7.56e-05 | 3 | 115 | 2 | CID003081567 | |
| Drug | fentanyl isothiocyanate | 8.11e-05 | 17 | 115 | 3 | CID000084008 | |
| Drug | chelerythrine | 8.46e-05 | 357 | 115 | 9 | CID000002703 | |
| Drug | benzodiazepine | 8.53e-05 | 142 | 115 | 6 | CID000134664 | |
| Drug | spiradoline | 8.56e-05 | 46 | 115 | 4 | CID000005620 | |
| Drug | acetylcholine | 9.21e-05 | 361 | 115 | 9 | CID000000187 | |
| Drug | AC1L1KC5 | CACNA1E F2R F2RL1 EXOSC2 BDKRB2 ADCY9 CHRNB1 KCNN1 TRPV6 LRBA TRPV5 | 9.45e-05 | 541 | 115 | 11 | CID000005428 |
| Drug | Bay K 8644 | 1.15e-04 | 150 | 115 | 6 | CID000002303 | |
| Drug | galactomannan | 1.19e-04 | 50 | 115 | 4 | CID000439336 | |
| Drug | U69,593 | 1.39e-04 | 52 | 115 | 4 | CID000105104 | |
| Drug | AC1L1DXE | 1.41e-04 | 299 | 115 | 8 | CID000002548 | |
| Drug | gamma-aminobutyric acid | GABRG1 CACNA1E SLC36A1 ADCY9 CHRNB1 OPRD1 OPRK1 ZACN TRPV6 GABRA6 | 1.48e-04 | 474 | 115 | 10 | CID000000119 |
| Drug | Dynorphins | 1.51e-04 | 4 | 115 | 2 | ctd:D004399 | |
| Drug | AC1L5BQM | 1.51e-04 | 4 | 115 | 2 | CID000174892 | |
| Drug | Diprenorphine | 1.51e-04 | 4 | 115 | 2 | DB01548 | |
| Drug | 3B-b | 1.51e-04 | 4 | 115 | 2 | CID000533975 | |
| Drug | picenadol | 1.51e-04 | 4 | 115 | 2 | CID000053076 | |
| Drug | sulforhodamine B acid chloride | 1.51e-04 | 4 | 115 | 2 | CID000065223 | |
| Drug | Naltrexone | 1.51e-04 | 4 | 115 | 2 | DB00704 | |
| Drug | Ions | 1.51e-04 | 4 | 115 | 2 | ctd:D007477 | |
| Drug | Methadyl Acetate | 1.51e-04 | 4 | 115 | 2 | ctd:D008692 | |
| Drug | 7-hydroxymitragynine | 1.51e-04 | 4 | 115 | 2 | ctd:C482678 | |
| Drug | Npys | 1.56e-04 | 21 | 115 | 3 | CID000129283 | |
| Drug | flumazenil | 1.61e-04 | 54 | 115 | 4 | CID000003373 | |
| Drug | lidocaine | 1.64e-04 | 160 | 115 | 6 | CID000003676 | |
| Drug | GTP[S] | CACNA1E OXER1 BDKRB2 ADCY9 OPRD1 OPRK1 SCN7A TRPV6 GNA15 LRBA SCN3B | 2.04e-04 | 591 | 115 | 11 | CID000001764 |
| Drug | beta-CNA | 2.07e-04 | 23 | 115 | 3 | CID005486190 | |
| Drug | AC1L8UHC | 2.07e-04 | 23 | 115 | 3 | CID000432954 | |
| Drug | thiophene-3-carboximidamide | 2.07e-04 | 23 | 115 | 3 | CID002779692 | |
| Drug | etorphine | 2.27e-04 | 59 | 115 | 4 | CID000026721 | |
| Drug | 5 beta-pregnanediol | 2.42e-04 | 60 | 115 | 4 | CID000012547 | |
| Drug | Dihydromorphine | 2.50e-04 | 5 | 115 | 2 | DB01565 | |
| Drug | metkephamid acetate | 2.50e-04 | 5 | 115 | 2 | CID005464183 | |
| Drug | R-84760 | 2.50e-04 | 5 | 115 | 2 | CID000133035 | |
| Drug | Naloxone | 2.50e-04 | 5 | 115 | 2 | DB01183 | |
| Drug | DALECK | 2.50e-04 | 5 | 115 | 2 | CID015942760 | |
| Drug | GPA 1657 | 2.50e-04 | 5 | 115 | 2 | CID000030503 | |
| Drug | RLH-033 | 2.50e-04 | 5 | 115 | 2 | CID000190867 | |
| Drug | Mr2097 | 2.50e-04 | 5 | 115 | 2 | CID005745592 | |
| Drug | K 185 | 2.50e-04 | 5 | 115 | 2 | CID005311198 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 4.90e-08 | 3 | 109 | 3 | DOID:0060393 (implicated_via_orthology) | |
| Disease | mean platelet volume | CUL4A ARHGAP32 RIN3 RNPEPL1 ZMYND8 SIK3 F2R F2RL1 OPRD1 DOCK5 FAR2 OR4A16 SYNE2 LRRC8A DPY19L2P2 | 5.31e-06 | 1020 | 109 | 15 | EFO_0004584 |
| Disease | RENAL CELL CARCINOMA, NONPAPILLARY | 2.81e-04 | 7 | 109 | 2 | 144700 | |
| Disease | Hereditary clear cell renal cell carcinoma | 2.81e-04 | 7 | 109 | 2 | C1333985 | |
| Disease | Nonpapillary renal cell carcinoma | 2.81e-04 | 7 | 109 | 2 | cv:CN074294 | |
| Disease | platelet component distribution width | CUL4A RIN3 RNPEPL1 ZMYND8 F2R DOCK5 CYFIP1 FAR2 XPO7 SLC66A3 | 4.96e-04 | 755 | 109 | 10 | EFO_0007984 |
| Disease | level of Ceramide (d40:1) in blood serum | 7.28e-04 | 11 | 109 | 2 | OBA_2045185 | |
| Disease | ovary epithelial cancer (is_marker_for) | 1.03e-03 | 13 | 109 | 2 | DOID:2152 (is_marker_for) | |
| Disease | Withdrawal Symptoms | 1.31e-03 | 58 | 109 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.31e-03 | 58 | 109 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.31e-03 | 58 | 109 | 3 | C0038587 | |
| Disease | RASopathy | 1.38e-03 | 15 | 109 | 2 | cv:C5555857 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.66e-03 | 63 | 109 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | emphysema pattern measurement | 2.22e-03 | 19 | 109 | 2 | EFO_0005850 | |
| Disease | photoreceptor cell layer thickness measurement | 2.25e-03 | 148 | 109 | 4 | EFO_0803370 | |
| Disease | epilepsy (implicated_via_orthology) | 3.18e-03 | 163 | 109 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 3.23e-03 | 268 | 109 | 5 | C0001973 | |
| Disease | Noonan Syndrome | 3.54e-03 | 24 | 109 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSIDRYLALVKTMSM | 151 | P30411 | |
| LERMSQMYEIILFTA | 336 | Q05D32 | |
| EYTIMAMIALNTVVL | 1481 | Q15878 | |
| TMSSVKILYVRNLML | 226 | Q9NQ94 | |
| FMDVYQLASTRIMTL | 1206 | Q6TFL3 | |
| TVTIYMMNVALVDLI | 56 | Q14330 | |
| YLMFTMVLVTFSVIL | 311 | P11230 | |
| VTTEMLKMATRYREL | 161 | O95841 | |
| RYEMLKSSTLIIQSM | 1416 | Q8IZT6 | |
| VMETVKILYVRNLMI | 241 | A0AV96 | |
| VEIITAVMLIFMSYD | 206 | Q8NGY2 | |
| MSALYSLLQILMVVR | 151 | Q15622 | |
| VFTDYISIVMLMIAV | 26 | Q8IWT6 | |
| MILNTIYEKVAIMIT | 521 | Q4KMQ2 | |
| MFSYILLTMCRNLIT | 1096 | Q9NRD9 | |
| STQLYMVRTMLESLI | 556 | Q7L576 | |
| MNRLLRTVSMLEYFI | 381 | Q96K12 | |
| SIITIMMDRIYLINS | 171 | Q8NFG4 | |
| SIYMDTLNIFMRVAT | 321 | Q9H3K2 | |
| RMTTALILYSAIFMR | 56 | P0DKB6 | |
| MDLRTRYTALVTLMT | 1401 | Q03001 | |
| ITFNTRFVMKTLMTI | 266 | Q92952 | |
| VLSRTMDYLVTQIMD | 696 | O60318 | |
| TVLMIAIQLITRMEY | 141 | P78368 | |
| DKLMTVFYSIITLML | 266 | Q8NH70 | |
| MMVSVFYTILTPVLN | 276 | Q6IEZ7 | |
| EMTLLIIMAFDRYVA | 111 | Q8NH43 | |
| EQRVISVMFLLMYTA | 21 | Q8NH49 | |
| NRIIMRMEYLKAVIT | 131 | Q9HD23 | |
| RLMLQTNLITMTTYN | 771 | P50851 | |
| FRIMQNGTILYTMRL | 136 | Q16445 | |
| LVYQNIFVSMRAMIE | 81 | P30679 | |
| FMDQDRIVAIMYTVV | 266 | P58182 | |
| SLLYMVRTMLESLIA | 581 | Q96F07 | |
| KIIYMNMISVTLSFI | 371 | Q6NUT2 | |
| VTQMLMAYLSRLSAI | 211 | A7KAX9 | |
| MVYEMVQRILLSTRG | 386 | Q2PPJ7 | |
| IISLVTQRMMLYDTS | 241 | Q13868 | |
| LRTMNSLKQLYTVTM | 151 | Q9H0A0 | |
| CMVVVLFLMITASTY | 166 | Q9NPH5 | |
| QRAMRVLAMVVAVYT | 291 | Q8TDS5 | |
| IFTLTMMSVDRYIAV | 136 | P41143 | |
| MDQDRITAIMYTVVT | 261 | P0DN82 | |
| MMVSVFYTILTPVLN | 276 | Q8NH02 | |
| MYASILLMTVISIDR | 186 | P25116 | |
| FLTASAYVLMIRMLR | 256 | P55085 | |
| YLVFTMIFVTLSIMV | 316 | P30532 | |
| FRLLQETMYMTVSII | 216 | P14635 | |
| YILSQPFMVRIMATE | 331 | Q8NFQ6 | |
| IAMETYIRQRQLIMS | 351 | Q9H7D0 | |
| TYLFMVQARGIMLRE | 41 | Q9UBX8 | |
| SIDTDVYFIIMMRTA | 191 | Q8WWF8 | |
| RVFALAYSMMTTQVL | 201 | Q6ZMU1 | |
| TTETIRIRYFMDLLM | 2431 | Q9UFH2 | |
| DYVIMTIFFDLSRRM | 256 | Q8N1C3 | |
| MIMIRSIFLFLDRTY | 146 | Q13619 | |
| TLQMALSYIMALTRI | 81 | Q8N100 | |
| SIYFAVHMRSRLIVM | 131 | O60503 | |
| TTIIILVLGMSMYYR | 266 | Q8N4S9 | |
| MVIFTLSVSMLLRYS | 311 | Q4ZIN3 | |
| DVNTTIMELLIMVYA | 81 | O60256 | |
| SMILMVIIRYISRVL | 226 | Q8WWI5 | |
| ETSNMMEYVILIEFL | 201 | Q5VXU3 | |
| IQVVISYFLMLIFMT | 141 | O15431 | |
| MTMLTIEQLSYLLKF | 146 | Q9ULU4 | |
| YMIISRDVMLIAAVF | 196 | Q9UJA2 | |
| KIIYMNMISVTLSFI | 181 | Q6ZN68 | |
| MSVYLVRQLTSAMLL | 291 | O75928 | |
| LMYVLARSNLTEMLL | 791 | Q8TB24 | |
| LIMTFTATELIMFYI | 106 | P03905 | |
| YTLIMTRELCTQMLG | 136 | Q8NGQ4 | |
| IFTLTMMSVDRYIAV | 146 | P41145 | |
| LMMISYFQIFSTVLR | 211 | A6ND48 | |
| MESIVLVAMAFDRYI | 116 | Q6IFG1 | |
| LMCMLIFSILITSYV | 226 | Q8NGB2 | |
| VTAQATVLMYILRMA | 246 | Q8WU17 | |
| AELMAMVRSIISLYF | 161 | A6NKG5 | |
| MVRSIISLYFRMQDL | 166 | A6NKG5 | |
| FEYAILMTMVLTIFI | 176 | Q86TM6 | |
| VRRFLESQMSRMYTI | 621 | Q9HAU8 | |
| STELRVLLSVMYLMV | 196 | Q9ULQ0 | |
| IIMEATCLMDRYQTL | 2011 | Q8WXH0 | |
| TNIYMLRMLSIVSEV | 346 | Q8NB12 | |
| SMYFSAVMVRLMLVL | 396 | P46977 | |
| IRLYQVMETERMIYL | 126 | Q9Y2K2 | |
| IFTVIMSRMILGEYT | 181 | P0CK97 | |
| LMAVIYTDALQTVIM | 206 | Q2M3M2 | |
| IRTMVFPVMYLNESV | 401 | Q14108 | |
| YRSTLERMLDVTMLQ | 546 | Q07889 | |
| LYMVTMSQKLRVELT | 131 | Q8NGL0 | |
| SYLMVIQDITAMVRF | 151 | Q8IZS7 | |
| IRRMMETFQQLITYK | 336 | Q05086 | |
| MVVVSAIQVYMLKSL | 206 | Q9Y3A6 | |
| ITMLVSLVMIYQFIV | 226 | Q7Z2H8 | |
| ITYDELVLMMQRVFR | 31 | Q92734 | |
| LMELFYSVTMAARIA | 121 | P41440 | |
| ILYSTDIALITMMLE | 86 | Q96FX7 | |
| LYTIFIVATKITMMT | 211 | Q9NVV0 | |
| IMMYILRTVFERAID | 886 | Q8IWV7 | |
| HVLIITYAFMVLVTM | 466 | Q9H1D0 | |
| TYAFMVLVTMVMRLI | 471 | Q9H1D0 | |
| ASIETMMLNLVRYVR | 986 | P21359 | |
| VYRLSMSLMEQLLKT | 1396 | Q5SRE5 | |
| VVSEIMMYILLVFLT | 156 | Q9NY72 | |
| IFTVIMSRMILGEYT | 181 | P0CK96 | |
| IAAIMAMRYNRLTVL | 116 | Q9HC07 | |
| MTTNDFTILLRFVIM | 166 | Q8N755 | |
| VFNVDILRYTMSSML | 71 | Q401N2 | |
| TRFMEVEVAIRLLYM | 441 | O43592 | |
| ILLFRETSKMITMYG | 796 | Q9UIA9 | |
| TRVALDMTTLTIMRY | 96 | P62333 | |
| INSIFVMLYTMECIL | 1286 | Q01118 | |
| FERLMTIYLSTKTAM | 561 | Q14139 | |
| YMMNSVLENFTILLV | 376 | P28347 | |
| MYIEIVMVSETIHFL | 2061 | Q9BXT5 | |
| IEFMRLTVSDMLVTY | 581 | Q8TDI7 | |
| RSVSTMLYLMALQEL | 996 | Q8IY18 | |
| LMIMLSRFELYQIFS | 711 | Q8IWV8 | |
| ISELNYMTQIVIMLY | 876 | Q6PFW1 | |
| TYASLVLVTMVMRLT | 431 | Q9NQA5 | |
| LYQLIRMATITMQAY | 826 | Q9NQX4 |